Carmelo Quarta; Erika Cantelli; Cristina Nanni; Valentina Ambrosini; Daniela D’ambrosio; Korinne Di Leo; Silvia Angelucci; Federico Zagni; Filippo Lodi; Mario Marengo; William A. Weiss; Andrea Pession; Roberto Tonelli; Stefano Fanti, Molecular Imaging of Neuroblastoma
Progression in TH-MYCN Transgenic Mice, «MOLECULAR IMAGING AND BIOLOGY», 2013, 15(2), pp. 194 - 202 [articolo]
Nanni C; Zamagni E; Celli M; Caroli P; Ambrosini V; Tacchetti P; Brioli A; Zannetti B; Pezzi A; Pantani L; Perrone G; Zompatori M; Cavo M; Colletti PM; Rubello D; Fanti S., The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. e74 - e79 [articolo]
Nanni C; Zompatori M; Ambrosini V; Montesi V; Mezzetti S; Ferretti A; Chondrogiannis S; Rubello D; Fanti S., The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients., «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2013, 67, pp. 172 - 178 [articolo]
Nanni C; Schiavina R; Rubello D; Ambrosini V; Brunocilla E; Martorana G; Fanti S, The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?, «NUCLEAR MEDICINE COMMUNICATIONS», 2013, 34, pp. 831 - 833 [articolo]
Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti, 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL, in: Supplement, «THE JOURNAL OF NUCLEAR MEDICINE», 2012, pp. N/A - N/A (atti di: SNMMI Annual Meeting, Miami, 10 Giugno 2012) [atti di convegno-abstract]
Nicolini S.; Ambrosini V.; Fantini L.; Fanti S., 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level., «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 591 - 592 [articolo]
Ambrosini V.; Campana D.; Tomassetti P.; Fanti S., 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39 Suppl 1., pp. 52 - 60 [articolo]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [articolo]
Nanni, C; Taglieri, N; Bonfiglioli, R; Ambrosini, V; Rapezzi, C; Branzi, A; Vagnarelli, F; Buia, F; Lovato, L; Saia, F; Fanti, S (Fanti, Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 427 - 427 [abstract]
Treglia G; Castaldi P; Villani MF; Perotti G; de Waure C; Filice A; Ambrosini V; Cremonini N; Santimaria M; Versari A; Fanti S; Giordano A; Rufini V., Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 569 - 580 [articolo]
Rubello D; Wong KK; Marzola MC; Beheshti M; Ambrosini V; Chondrogiannis S; Gross MD., Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 563 - 568 [articolo]
Ambrosini V.; Savelli F.; Merli E.; Zompatori M.; Nanni C.; Allegri V.; Fanti S., F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease, «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 196 - 197 [articolo]
C. Nanni;L. Boriani;C. Salvadori;E. Zamparini;G. Rorato;V. Ambrosini;A. Gasbarrini;F. Tumietto;F. Cristini;L. Scudeller;S. Boriani;P. Viale;S. Fanti, FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1538 - 1544 [articolo]
Ambrosini V.; Campana D.; Nanni C.; Cambioli S.; Tomassetti P.; Rubello D.; Fanti S., Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1278 - 1283 [articolo]
V. Ambrosini; D. Campana; P. Tommassetti; S. Fanti, Neuroendocrine Tumours with Secondary Liver Lesions, in: Valentina Ambrosini Piero Amodio Lasse K. Bak Ignasi Barba Ludvik Bass Davide Campana Laia Chavarria Juan Córdoba Dominique Delbeke Stefano Fanti Kim Frisch Alan F. Hofmann Laurie B. Jones-Jackson Susanne Keiding Alan H. Lockwood Patricia Iozzo Mark J.W. McPhail Carlo Merkel Sara Montagnese Ole Lajord Munk Pirjo Nuutila Peter Ott Hanne Prytz Arne Schousboe Michael Sørensen Simon D. Taylor-Robinson Howard C. Thomas Paola Tomassetti Hendrik Vilstrup Helle S. Waagepetersen Ronald C. Walker, Functional Molecular Imaging In Hepatology, OAK PARK, bentham science pubblisher, 2012, pp. 120 - 128 [capitolo di libro]
